Week | Prednisone dose (oral) |
Week 1 | 60 mg/day |
Week 2 | 50 mg/day |
Week 3 | 40 mg/day |
Week 4 | 35 mg/day |
Week 5 | 30 mg/day |
Week 6 | 25 mg/day |
Week 7 | 20 mg/day |
Weeks 8 and 9 | 17.5 mg/day |
Weeks 10 and 11 | 15 mg/day |
Weeks 12 and 13 | 12.5 mg/day |
Weeks 14 and 15 | 10 mg/day |
Weeks 16 and 17 | 9 mg/day |
Weeks 18 and 19 | 8 mg/day |
Weeks 20 and 21 | 7 mg/day |
Weeks 22 and 23 | 6 mg/day¶ |
Weeks 24 and 25 | 5 mg/day |
Weeks 26 and 27 | 4.5 mg/day |
Weeks 28 and 29 | 4 mg/day |
Weeks 30 and 31 | 3.5 mg/day |
Weeks 32 and 33 | 3 mg/day |
Weeks 34 and 35 | 2.5 mg/day |
Weeks 36 and 37 | 2 mg/day |
Weeks 38 and 39 | 1.5 mg/day |
Weeks 40 and 41 | 1 mg/day |
Week 42 | Stop |
* Many factors influence the pace of systemic glucocorticoid withdrawal, including control of the underlying disease, adverse effects of glucocorticoids, patient age, clinical status, and response to prior glucocorticoid tapers. Tapers should be adjusted when there is concern for adrenal insufficiency (based on clinical symptoms and/or laboratory testing). For more information, refer to UpToDate content on glucocorticoid withdrawal and the disease specific treatment topic.
¶ Some experts use laboratory cortisol testing to help guide the taper after reaching a physiologic glucocorticoid dose (approximately 5 to 7.5 mg of prednisone). Testing involves omitting the glucocorticoid dose on the morning of the test and measuring an endogenous cortisol level at approximately 7 to 9 AM. For more information, refer to UpToDate content on the diagnosis of adrenal insufficiency.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟